Global proteogenomic analysis of human MHC class I-associated peptides derived from non-canonical reading frames

Nature Communications

Volumn 7, Issue , 2016, Pages

  Laumont, Céline M ^a,b   Daouda, Tariq ^a,b   Laverdure, Jean Philippe ^a   Bonneil, Éric ^a   Caron Lizotte, Olivier ^a   Hardy, Marie Pierre ^a   Granados, Diana P ^a,b   Durette, Chantal ^a   Lemieux, Sébastien ^a,b   Thibault, Pierre ^a,b   Perreault, Claude ^a,b,c  

^a INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1 ASSOCIATED PEPTIDE; MESSENGER RNA; PEPTIDE; TRANSCRIPTOME; UNCLASSIFIED DRUG;

CHEMICAL BINDING; COMPLEXITY; GENOMICS; IMMUNOASSAY; MAJOR HISTOCOMPATIBILITY COMPLEX; MASS SPECTROMETRY; PEPTIDE; PROBE; PROTEIN;

3' UNTRANSLATED REGION; ALLOTYPE; ANTIGEN BINDING; ARTICLE; B LYMPHOCYTE; BIOGENESIS; CARBOXY TERMINAL SEQUENCE; CD8+ T LYMPHOCYTE; CODON USAGE; CONTROLLED STUDY; DNA FLANKING REGION; GENETIC POLYMORPHISM; GENOMICS; GENOTYPE; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; IMMUNOGENICITY; IMMUNOSURVEILLANCE; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; OPEN READING FRAME; POLYMERASE CHAIN REACTION; PROTEOGENOMICS; PROTEOMICS; RNA SEQUENCE; RNA STABILITY; START CODON; TANDEM MASS SPECTROMETRY; GENE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PROCEDURES; READING FRAME;

GENE EXPRESSION REGULATION; GENES, MHC CLASS I; GENOTYPE; HUMANS; POLYMERASE CHAIN REACTION; PROTEOMICS; READING FRAMES; RNA, MESSENGER;

EID: 84953260622     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms10238     Document Type: Article

References (70)

1. Djebali, S. et al. Landscape of transcription in human cells. Nature 489, 101-108 (2012).
2. Kim, M. S. et al. A draft map of the human proteome. Nature 509, 575-581 (2014).
3. Weekes, M. P. et al. Quantitative temporal viromics: an approach to investigate host-pathogen interaction. Cell 157, 1460-1472 (2014).
4. Alfaro, J. A., Sinha, A., Kislinger, T. & Boutros, P. C. Onco-proteogenomics: cancer proteomics joins forces with genomics. Nat. Methods 11, 1107-1113 (2014).
5. Nesvizhskii, A. I. Proteogenomics: concepts, applications and computational strategies. Nat. Methods 11, 1114-1125 (2014).
6. Ingolia, N. T. et al. Ribosome profiling reveals pervasive translation outside of annotated protein-coding genes. Cell Rep. 8, 1365-1379 (2014).
7. Branca, R. M. et al. HiRIEF LC-MS enables deep proteome coverage and unbiased proteogenomics. Nat. Methods 11, 59-62 (2014).
8. Wilhelm, M. et al. Mass-spectrometry-based draft of the human proteome. Nature 509, 582-587 (2014).
9. Zhang, B. et al. Proteogenomic characterization of human colon and rectal cancer. Nature 513, 382-387 (2014).
10. Slavoff, S. A. et al. Peptidomic discovery of short open reading frame-encoded peptides in human cells. Nat. Chem. Biol. 9, 59-64 (2013).
11. Caron, E. et al. The MHC I immunopeptidome conveys to the cell surface an integrative view of cellular regulation. Mol. Syst. Biol. 7, 533 (2011).
12. Hassan, C. et al. The human leukocyte antigen-presented ligandome of B lymphocytes. Mol. Cell Proteomics 12, 1829-1843 (2013).
13. Mester, G., Hoffmann, V. & Stevanovic, S. Insights into MHC class I antigen processing gained from large-scale analysis of class I ligands. Cell Mol. Life Sci. 68, 1521-1532 (2011).
14. Granados, D. P., Laumont, C. M., Thibault, P. & Perreault, C. The nature of self for T cells - a systems-level perspective. Curr. Opin. Immunol. 34, 1-8 (2015).
15. Lev, A. et al. Compartmentalized MHC class I antigen processing enhances immunosurveillance by circumventing the law of mass action. Proc. Natl Acad. Sci. USA 107, 6964-6969 (2010).
16. de Verteuil, D., Granados, D. P., Thibault, P. & Perreault, C. Origin and plasticity of MHC I-associated self peptides. Autoimmun. Rev. 11, 627-635 (2012).
17. Malarkannan, S., Afkarian, M. & Shastri, N. A rare cryptic translation product is presented by Kb major histocompatibility complex class I molecule to alloreactive T cells. J Exp. Med. 182, 1739-1750 (1995).
18. Starck, S. R. et al. Leucine-tRNA initiates at CUG start codons for protein synthesis and presentation by MHC class I. Science 336, 1719-1723 (2012).
19. Starck, S. R. & Shastri, N. Non-conventional sources of peptides presented by MHC class I. Cell Mol. Life Sci. 68, 1471-1479 (2011).
20. Goodenough, E. et al. Cryptic MHC class I-binding peptides are revealed by aminoglycoside-induced stop codon read-through into the 3′UTR. Proc. Natl Acad. Sci. USA 111, 5670-5675 (2014).
21. Weinzierl, A. O. et al. A cryptic vascular endothelial growth factor T-cell epitope: identification and characterization by mass spectrometry and T-cell assays. Cancer Res. 68, 2447-2454 (2008).
22. Granados, D. P. et al. Impact of genomic polymorphism on the repertoire of human MHC class I-associated peptides. Nat. Commun. 5, 3600 (2014).
23. Daouda, T. pyGeno: a Python package for precision medicine https://github.com/tariqdaouda/pyGeno (2015).
24. Nesvizhskii, A. I. A survey of computational methods and error rate estimation procedures for peptide and protein identification in shotgun proteomics. J. Proteomics 73, 2092-2123 (2010).
25. Sidney, J., Southwood, S., Pasquetto, V. & Sette, A. Simultaneous prediction of binding capacity for multiple molecules of the HLA B44 supertype. J. Immunol. 171, 5964-5974 (2003).
26. Pelechano, V. & Steinmetz, L. M. Gene regulation by antisense transcription. Nat. Rev. Genet. 14, 880-893 (2013).
27. Harrow, J. et al. GENCODE: the reference human genome annotation for The ENCODE Project. Genome Res. 22, 1760-1774 (2012).
28. Andrews, S. J. & Rothnagel, J. A. Emerging evidence for functional peptides encoded by short open reading frames. Nat. Rev. Genet. 15, 193-204 (2014).
29. Apcher, S. et al. Translation of pre-spliced RNAs in the nuclear compartment generates peptides for the MHC class I pathway. Proc. Natl Acad. Sci. USA 110, 17951-17956 (2013).
30. Granados, D. P. et al. MHC I-associated peptides preferentially derive from transcripts bearing miRNA response elements. Blood 119, e181-e191 (2012).
31. Yadav, M. et al. Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing. Nature 515, 572-576 (2014).
32. Yewdell, J. W. DRiPs solidify: progress in understanding endogenous MHC class I antigen processing. Trends Immunol. 32, 548-558 (2011).
33. Apcher, S. et al. Major source of antigenic peptides for the MHC class I pathway is produced during the pioneer round of mRNA translation. Proc. Natl Acad. Sci. USA 108, 11572-11577 (2011).
34. Smith, J. E. et al. Translation of small open reading frames within unannotated RNA transcripts in Saccharomyces cerevisiae. Cell Rep. 7, 1858-1866 (2014).
35. Kim, Y., Yewdell, J. W., Sette, A. & Peters, B. Positional bias of MHC class I restricted T-cell epitopes in viral antigens is likely due to a bias in conservation. PLoS Comput. Biol. 9, e1002884 (2013).
36. Zhao, W. et al. Massively parallel functional annotation of 3′ untranslated regions. Nat. Biotechnol. 32, 387-391 (2014).
37. Ivanov, I. P., Loughran, G., Sachs, M. S. & Atkins, J. F. Initiation context modulates autoregulation of eukaryotic translation initiation factor 1 (eIF1). Proc. Natl Acad. Sci USA 107, 18056-18060 (2010).
38. Ingolia, N. T., Lareau, L. F. & Weissman, J. S. Ribosome profiling of mouse embryonic stem cells reveals the complexity and dynamics of mammalian proteomes. Cell 147, 789-802 (2011).
39. Yewdell, J. W., Reits, E. & Neefjes, J. Making sense of mass destruction: quantitating MHC class I antigen presentation. Nat. Rev. Immunol. 3, 952-961 (2003).
40. Blum, J. S., Wearsch, P. A. & Cresswell, P. Pathways of antigen processing. Annu. Rev. Immunol. 31, 443-473 (2013).
41. Weimershaus, M., Evnouchidou, I., Saveanu, L. & van Endert, P. Peptidases trimming MHC class I ligands. Curr. Opin. Immunol. 25, 90-96 (2013).
42. de Verteuil, D. et al. Deletion of immunoproteasome subunits imprints on the transcriptome and has a broad impact on peptides presented by major histocompatibility complex I molecules. Mol. Cell Proteomics 9, 2034-2047 (2010).
43. Neefjes, J., Jongsma, M. L. M., Paul, P. & Bakke, O. Towards a systems understanding of MHC class I and MHC class II antigen presentation. Nat. Rev. Immunol. 11, 823-836 (2011).
44. Mishto, M. et al. Proteasome isoforms exhibit only quantitative differences in cleavage and epitope generation. Eur. J. Immunol. 44, 3508-3521 (2014).
45. Elkon, R., Ugalde, A. P. & Agami, R. Alternative cleavage and polyadenylation: extent, regulation and function. Nat. Rev. Genet. 14, 496-506 (2013).
46. David, A. et al. Nuclear translation visualized by ribosome-bound nascent chain puromycylation. J. Cell Biol. 197, 45-57 (2012).
47. Princiotta, M. F. et al. Quantitating protein synthesis, degradation, and endogenous antigen processing. Immunity 18, 343-354 (2003).
48. Apcher, S., Manoury, B. & Fahraeus, R. The role of mRNA translation in direct MHC class I antigen presentation. Curr. Opin. Immunol. 24, 71-76 (2012).
49. Bourdetsky, D., Schmelzer, C. E. & Admon, A. The nature and extent of contributions by defective ribosome products to the HLA peptidome. Proc. Natl Acad. Sci. USA 111, E1591-E1599 (2014).
50. Quax, T. E., Claassens, N. J., Soll, D. & van der Oost, J. Codon bias as a means to fine-tune gene expression. Mol. Cell 59, 149-161 (2015).
51. Boon, T. & Van Pel, A. T cell-recognized antigenic peptides derived from the cellular genome are not protein degradation products but can be generated directly by transcription and translation of short subgenic regions. A hypothesis. Immunogenetics 29, 75-79 (1989).
52. van Rooij, N. et al. Tumor exome analysis reveals neoantigen-specific T-cell reactivity in an ipilimumab-responsive melanoma. J. Clin. Oncol. 31, e439-e442 (2013).
53. Robbins, P. F. et al. Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells. Nat. Med. 19, 747-752 (2013).
54. Gubin, M. M. et al. Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens. Nature 515, 577-581 (2014).
55. White, N. M. et al. Transcriptome sequencing reveals altered long intergenic non-coding RNAs in lung cancer. Genome Biol. 15, 429 (2014).
56. Trimarchi, T. et al. Genome-wide mapping and characterization of Notch-regulated long noncoding RNAs in acute leukemia. Cell 158, 593-606 (2014).
57. Coulie, P. G., Van den Eynde, B. J., van der Bruggen, P. & Boon, T. Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy. Nat. Rev. Cancer 14, 135-146 (2014).
58. Hinrichs, C. S. & Restifo, N. P. Reassessing target antigens for adoptive T-cell therapy. Nat. Biotechnol. 31, 999-1008 (2013).
59. Heemskerk, B., Kvistborg, P. & Schumacher, T. N. The cancer antigenome. EMBO J. 32, 194-203 (2013).
60. Kim, D. et al. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol. 14, R36 (2013).
61. Trapnell, C. et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat. Biotechnol. 28, 511-515 (2010).
62. Thibault, P. ProteoProfile https://proteomics. iric. ca/tools/ProteoProfile/ (2015).
63. Sennels, L., Bukowski-Wills, J. C. & Rappsilber, J. Improved results in proteomics by use of local and peptide-class specific false discovery rates. BMC Bioinformatics 10, 179 (2009).
64. Karosiene, E., Lundegaard, C., Lund, O. & Nielsen, M. NetMHCcons: a consensus method for the major histocompatibility complex class I predictions. Immunogenetics 64, 177-186 (2012).
65. Blakeley, P., Overton, I. M. & Hubbard, S. J. Addressing statistical biases in nucleotide-derived protein databases for proteogenomic search strategies. J. Proteome Res. 11, 5221-5234 (2012).
66. Fortier, M. H. et al. The MHC class I peptide repertoire is molded by the transcriptome. J. Exp. Med. 205, 595-610 (2008).
67. GenScript bioinformatic tools. GenScript codon usage frequence table tool http://www.genscript. com/cgi-bin/tools/codon-freq-table (2015).
68. Bollard, C. M. et al. Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer. Blood 110, 2838-2845 (2007).
69. Wolfl, M. & Greenberg, P. D. Antigen-specific activation and cytokine-facilitated expansion of naive, human CD8+ T cells. Nat. Protoc. 9, 950-966 (2014).
70. Vincent, K. et al. Rejection of leukemic cells requires antigen-specific T cells with high functional avidity. Biol. Blood Marrow Transplant. 20, 37-45 (2014).